Reproductive Freedom for All Slams Fifth Circuit Case That Threatens Mifepristone Access Nationwide Ahead of Oral Arguments

MorganSeptember 19, 2026

The U.S. Court of Appeals for the Fifth Circuit will hear oral arguments in Louisiana v. U.S. Food and Drug Administration (FDA), a lawsuit seeking to end mail and pharmacy access to mifepristone nationwide—including in states where abortion is protected.

Anti-abortion GOP Healthcare Louisiana Red States Reproductive rights United States

By Morgan